Anti‐vascular endothelial growth factor therapy vs conventional laser/cryotherapy
Local adverse effects ‐ corneal opacity requiring corneal transplant (unit of analysis: eyes) · preterm infants with type 1 ROP
It is very uncertain whether anti‐vascular endothelial growth factor therapy changes local adverse effects ‐ corneal opacity requiring corneal transplant… compared with conventional laser/cryotherapy (very low certainty).
1 finding from 1 review
- Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity 2018 · Cochrane Headline outcomes onlyRR 0.34 [0.01, 8.26]1 study · 286 participantsVery low